The MAHs should discuss the benefit/ risk balance of the product, with special regard to: • the merits of using sodium salicylate as an oral medication for mass administration in cattle and pigs when individual treatment with parenteral NSAIDs may offer more precise therapy; • the use for analgesic and antipyretic effects under field condition, bearing in mind that the use in young animals which are suffering disease stress may lead to a potentiation of the undesirable effects of salicylate toxicity.